PMID: 12757869May 22, 2003Paper

Skeletal muscle satellite cell transplantation

Cardiovascular Research
Philippe Menasché

Abstract

Cell transplantation is currently gaining a growing interest as a potential new means of improving the prognosis of patients with cardiac failure. The basic assumption is that left ventricular dysfunction is primarily caused by the loss of a critical number of cardiomyocytes and that their replacement by new contractile cells could functionally 'regenerate' postinfarction scars in which these cells are implanted. Primarily for practical reasons, autologous skeletal myoblasts have been the first to undergo clinical trials but other cell types are also considered, particularly bone marrow stem cells which are attractive because of their autologous origin and their purported cardiomyocyte/endothelial transdifferentiation potential in response to cues present in the target organ. However, several key issues still need to be addressed including (1) the optimal type of donor cells, (2) the mechanism by which cell engraftment improves cardiac function, (3) the optimization of cell survival, and (4) the potential benefits of cell transplantation in nonischemic dilated cardiomyopathies. In parallel to the experimental studies designed to address these issues, clinical trials are underway and their results should hopefully allow the asse...Continue Reading

Citations

Apr 10, 2007·Annals of Biomedical Engineering·Bryce H DavisDoris A Taylor
Sep 22, 2005·The International Journal of Cardiovascular Imaging·Arjang RuhparwarUlrich Martin
Jan 8, 2008·Cardiovascular Toxicology·Nikki Gillum, Narine Sarvazyan
Nov 3, 2005·Nature Clinical Practice. Cardiovascular Medicine·Noel M Caplice, Arjun Deb
Aug 25, 2009·European Heart Journal·Juan José GaviraFelipe Prósper
Oct 23, 2012·Journal of Biomechanical Engineering·Bryce H DavisDoris A Taylor
Oct 18, 2007·Proceedings of the National Academy of Sciences of the United States of America·Atsushi AsakuraMichael A Rudnicki
Aug 27, 2004·Médecine sciences : M/S·Jean-Thomas Vilquin, Jean-Pierre Marolleau
Jul 31, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Young-Wook WonSung Wan Kim
Aug 17, 2005·The American Journal of the Medical Sciences·Daniel J GarryPradeep P A Mammen
May 1, 2010·Cytotherapy·Chung-Dann KanYu-Jen Yang
Oct 13, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mei OuSung Wan Kim
Aug 30, 2008·Journal of the American College of Surgeons·Nathan M NovotnyDaniel R Meldrum
Oct 28, 2009·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Eric LaroseJacques P Tremblay
Mar 16, 2005·Revista española de cardiología·Felipe Prósper
Oct 8, 2004·Revista española de cardiología·Felipe PrósperJoaquín Barba
Apr 29, 2006·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Christoph BaraArjang Ruhparwar
Mar 29, 2006·Heart Rhythm : the Official Journal of the Heart Rhythm Society·M Roselle Abraham, Joshua M Hare
Apr 10, 2008·Cell Stem Cell·Silvia Martin-PuigKenneth R Chien
Apr 4, 2006·The Journal of Thoracic and Cardiovascular Surgery·Juan J GaviraFelipe Prósper
Oct 11, 2005·The Journal of Thoracic and Cardiovascular Surgery·Patrick I McConnellRobert E Michler
Jun 6, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lieven ThorrezThierry Vandendriessche
Jun 16, 2011·The Journal of International Medical Research·L ChenJ G Xu
Jun 9, 2009·Cell Transplantation·Monika SeidelMaciej Kurpisz
Jun 25, 2005·Circulation Research·M Roselle AbrahamEduardo Marbán
Jan 1, 2008·Annals of Vascular Diseases·Kaoru TatenoIssei Komuro
Dec 2, 2009·Current Opinion in Organ Transplantation·Soon Jun HongKeith L March
Feb 28, 2006·Nature Clinical Practice. Cardiovascular Medicine·Paul SteendijkPatrick W Serruys
Aug 21, 2012·Toxicology Mechanisms and Methods·Yuan LiuWei Zhu
Sep 19, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Eva ZebedinKarlheinz Hilber
Jun 17, 2004·Journal of Cell Science·Joanne C CousinsJennifer E Morgan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

© 2022 Meta ULC. All rights reserved